Recent research indicates that fetuses may be exposed to significantly higher concentrations of per- and polyfluoroalkyl substances (PFAS)—commonly known as “forever chemicals”—than previously understood. A study conducted by Mount Sinai has unveiled a startling number of these compounds in umbilical cord blood, raising critical health concerns for newborns.
Comprehensive Testing Uncovers Hidden Compounds
Traditionally, testing of umbilical cord blood has focused on a limited selection of PFAS compounds, primarily PFOA and PFOS. However, a new analytical technique employed by researchers at Mount Sinai analysed 120 umbilical cord blood samples, which had previously been identified to contain only a few PFAS. This expanded “non-targeted analysis” identified a total of 42 distinct PFAS compounds across these samples, revealing higher overall levels of PFAS in fetal blood than previously documented.
Shelley Liu, an associate professor at the Icahn School of Medicine and a co-author of the study, emphasised the significance of these findings. “Babies are exposed to many more PFAS than we previously thought,” she stated. The implications of such exposure are particularly concerning given the vulnerability of fetuses during this critical period of development.
Understanding PFAS and Their Risks
PFAS comprise a class of approximately 15,000 synthetic compounds widely utilised for their water, stain, and grease-resistant properties. Despite their usefulness, these chemicals have been linked to a multitude of health issues, including cancers, birth defects, weakened immune systems, high cholesterol, and kidney disease. Their persistence in the environment has earned them the nickname “forever chemicals,” as they do not break down naturally.
Research has shown that fetuses are particularly susceptible to PFAS exposure through umbilical cord blood. A review encompassing 40 studies found PFAS in 30,000 samples of umbilical cord blood. Elevated levels in mothers have been associated with increased infant mortality, low birth weight, and obesity in later life. Moreover, fetal exposure has been correlated with risks of cancer, neurological disorders, and cardiovascular issues as children grow.
Regulatory Oversight and Testing Gaps
The legacy PFAS compounds, such as PFOA and PFOS, have been phased out in recent years, yet their newer counterparts often enter the market without rigorous testing. While some manufacturers claim these newer PFAS are less harmful, evidence to substantiate such claims is lacking. The methods employed by regulatory bodies like the US Environmental Protection Agency (EPA) have not kept pace with the evolving landscape of PFAS compounds. Currently, the EPA’s water testing focuses on around 30-40 compounds, despite independent research identifying thousands in various environments.
Mount Sinai’s study demonstrated how the more thorough non-targeted analysis revealed 31 PFAS compounds that are not included in the EPA’s testing criteria. Liu highlighted that while the EPA has certified a blood test for 53 compounds, there remains a significant gap in our understanding and monitoring of these substances.
Future Directions and Health Implications
Although the Mount Sinai study did not directly assess the health impacts of the elevated PFAS levels found in the umbilical cord blood, the existing literature suggests a correlation between higher PFAS concentrations and increased health risks. The blood samples analysed were part of the federal government’s Home Study, which tracks PFAS exposure and its long-term health effects. Researchers aim to further investigate the potential health implications associated with these findings.
David Andrews, acting chief science officer at the Environmental Working Group, expressed concern regarding the study’s outcomes. He noted, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The findings from this groundbreaking study illuminate a critical public health issue, highlighting the need for more rigorous testing and regulation of PFAS compounds. The potential for numerous harmful chemicals to affect fetal development raises urgent questions about environmental safety and the health of future generations. As we continue to understand the full scope of PFAS exposure, it becomes increasingly important to advocate for stronger health protections to ensure that our youngest and most vulnerable populations are safeguarded from these persistent environmental pollutants.
